-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Organogenesis Holdings, Raises Price Target to $9

Benzinga·11/20/2025 12:51:54
Listen to the news
BTIG analyst Ryan Zimmerman maintains Organogenesis Holdings (NASDAQ:ORGO) with a Buy and raises the price target from $7 to $9.